Analogs of the dopamine D4 receptor ligand FAUC 113 with planar- and central-chirality

Tetrahedron Asymmetry

Volumn 13, Issue 21, 2002, Pages 2303-2310

  Löber, Stefan ^a   Ortner, Birgit ^a   Bettinetti, Laura ^a   Hübner, Harald ^a   Gmeiner, Peter ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

[2.2]PARACYCLOPHANE; AMINO ACID; CYCLOPHANE DERIVATIVE; DOPAMINE 4 RECEPTOR; FUNGAL ENZYME; LIGAND; PIPERAZINE DERIVATIVE; PYRAZOLO[1,5 A]PYRIDINE; PYRIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CATALYST; CHIRALITY; ENANTIOMER; IN VITRO STUDY; PRIORITY JOURNAL; SYNTHESIS; YEAST;

EID: 0037206785     PISSN: 09574166     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0957-4166(02)00639-0     Document Type: Article

References (23)

1. Van Tol H.H.M., Bunzow J.R., Guan H.-C., Sunahara R.K., Seeman P., Niznik H.B., Civelli O. Nature. 350:1991;610.
2. McCracken J.T., Smalley S.L., McGough J.J., Crawford L., Del'Homme M.A., Cantor R.M., Liu A., Nelson S.F. Mol. Psychiatr. 5:2000;531.
3. Lichter J.B., Barr C.L., Kennedy J.L., Van Tol H.H.M., Kid K.K., Livak K.J. Hum. Biol. Genet. 2:1993;767.
4. . For a review, see: Kulagowski J.J., Patel S. Curr. Pharm. Design. 3:1997;355. and references cited therein.
5. Löber S., Hübner H., Gmeiner P. Bioorg. Med. Chem. Lett. 9:1999;97.
6. Löber S., Hübner H., Utz W., Gmeiner P. J. Med. Chem. 44:2001;2691.
7. Löber S., Aboul-Fadl T., Hübner H., Gmeiner P. Bioorg. Med. Chem. Lett. 12:2002;633.
8. Prante O., Löber S., Hübner H., Gmeiner P., Kuwert T. J. Labelled Compd. Radiopharm. 44:2001;849.
9. Ortner B., Waibel R., Gmeiner P. Angew. Chem., Int. Ed. 40:2001;1283.
10. Ortner B., Hübner H., Gmeiner P. Tetrahedron: Asymmetry. 12:2001;3205.
11. Rossen K., Pye P.J., Maliakal A., Volante R.P. J. Org. Chem. 62:1997;6462.
12. Beller M., Breindl T.H., Riermeier T.H., Eichberger M., Trauthwein H. Angew. Chem., Int. Ed. 37:1999;3389.
13. Kanth J.V.B., Reddy C.K., Periasamy M. Synth. Commun. 24:1994;313.
14. Kiely J.S., Priebe S.R. Org. Prep. Proc. Int. 22:1990;761.
15. Tokunanga M., Larrow J.F., Kakiuchi F., Jacobsen E.N. Science. 277:1997;936.
16. Furrow M.E., Scott S.E., Jacobsen E.N. J. Org. Chem. 63:1998;6776.
17. Newman M.S., Fones W., Renoll M. J. Am. Chem. Soc. 69:1947;718.
18. Tanji K., Sasahara T., Suzuki J., Higashino T. Heterocycles. 35:1993;915.
19. Hayes G., Biden T.J., Selbie L.A., Shine J. J. Mol. Endocrinol. 6:1992;920.
20. Sokoloff P., Andrieux M., Besancon R., Pilon C., Martres M.-P., Giros B., Schwartz J.-C. Eur. J. Pharmacol. 225:1992;331.
21. Agashari V., Sanyal S., Buchwaldt S., Paterson A., Jovanovic V., Van Tol H.H.M. J. Neurochem. 65:1995;1157.
22. Hübner H., Haubmann C., Utz W., Gmeiner P. J. Med. Chem. 43:2000;756.
23. Both enantiomers of the (salen)Co(II) precatalyst are commercially available from Aldrich.